Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Which Credit Cards Offer Cash Rewards No Annual Fee
Discover credit cards that provide cash rewards without annual fees. Make your spending count!
26,108 articles
Even Higher-Income Americans Turning Pessimistic Yet
Geopolitical tensions and stubborn inflation are rattling markets. Even higher-income americans turning cautious sign...
Does SpaceX Tesla Merger Make Sense for Investors?
Could a SpaceX and Tesla merger reshape the future of tech and energy? This guide breaks down the potential benefits,...
What Does Sale Rapport Signal for Investors Today?
When a chief operating officer sells stock, investors take notice. This article breaks down the implications, explain...
Reddit Bearish Ford Numbers Deepen After Q4 Losses
Ford reveals a heavy Q4 loss tied to Model e impairments, renewing Reddit-driven skepticism about its EV turnaround a...
AMD Just Blew Earnings Wall as Analysts Push Targets Higher
AMD delivered a blockbuster quarter, topping expectations on both earnings and revenue. The market response was elect...
We’re Bullish on Amazon with 36% Upside From Here
Amazon faces a pullback even as cloud, ads, and silicon efforts pick up speed. Analysts see roughly 36% upside over t...
Alphabet's Trillion Dominance Facing Fresh Threats
Alphabet reports higher capital investment as it bets on AI and cloud, challenging the resilience of its trillion-dol...
Prosecutors Push Retry Tornado Co-Founder, Testing Privacy Debate
SDNY prosecutors seek a new trial for Tornado Cash co-founder Roman Storm in October 2026, even as U.S. agencies ackn...
Two Dividend Kings Likely to Stay in Berkshire Hathaway
Two Dividend Kings anchor Berkshire Hathaway's core holdings as Greg Abel takes the helm. Analysts say Coca-Cola and ...
Micron Just Locked $100 Billion, but Is the Boom Ending?
Micron Technology unveiled long-term contracts totaling about $100 billion in minimum revenue through 2030, sending s...
Late AppLovin After 1,428% Run: Is It Still a Buy?
AppLovin rode a massive multi-year rally, but a pivot to pure-play ad tech and a softening macro beat have investors ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status